Therapeutic Potential of Chausath Prahari Pippali Churna in the Management of Tamaka Shwasa: A Comprehensive Review

Abstract

Bronchial asthma is one of the chronic inflammatory illnesses of the respiratory tract, accounting for a large number of deaths each year. Increased development and pollution have exacerbated the situation. This dreadful illness is analogous to Tamaka Shwasa in Ayurvedic medicine. Synthetic medicines provide immediate symptom alleviation in bronchial asthma, but they are known to cause adverse medication reactions. Given this, the current suffering populace is resorting to alternative medical systems such as Ayurveda for healing.  Tamaka Shwasa, a condition analogous to bronchial asthma in Ayurveda, is a chronic respiratory disorder characterized by symptoms such as dyspnea, wheezing, and chest tightness. Conventional treatments often fall short of providing long-term relief, prompting the exploration of alternative therapies. Chausath Prahari Pippali Churna (CPPC), an Ayurvedic formulation, has shown potential in the management of respiratory ailments. This comprehensive review aims to elucidate the role of CPPC in the disintegration of Tamaka Shwasa pathogenesis. CPPC, composed of Pippali (Piper longum) processed for 64 Praharas (three days and three nights), possesses potent anti-inflammatory, bronchodilatory, and immunomodulatory properties. In this paper we will discuss. Pharmaceutico-Analytical Study of Chausathprahari Pippali Churna.